A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer TherapyTohru Nakagawa(Mayo Clinic), Robert B. Jenkins(Mayo Clinic)PLoS ONEMay 28, 200810.1371/journal.pone.0002318Cited by 180SaveCiteExport RISWatch citationsRelated PapersDiscovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy|PLoS ONE|2013|663